Trials / Completed
CompletedNCT03224546
Cocaine Use Reduction and Health
Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- William Stoops · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced cocaine use. These data will be used to change current accepted cocaine treatment endpoints and accelerate identification of therapies for cocaine use disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Contingency Management | Subjects will receive payments for providing cocaine negative urine samples. |
Timeline
- Start date
- 2017-09-15
- Primary completion
- 2024-01-15
- Completion
- 2024-01-15
- First posted
- 2017-07-21
- Last updated
- 2024-08-01
- Results posted
- 2024-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03224546. Inclusion in this directory is not an endorsement.